Trial intelligence / Profile preview

T-cell homeostasis after ATG-induced lymphocytopenia in renal transplant patients using in vivo deuterated water labeling

NL-OMON35541Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Oct 2011
Modality
Recombinant Proteins and Enzymes, Antibody-Based Therapeutics, Small Molecules
Countries
1
01

Overview

Open-label trial of antithymocyte globulin rabbit and deuterated water in kidney allograft rejection and lymphocytopenia (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: 2H2O incorporation into DNA of naive CD4+ and CD8+ T cells and Production rate and half-life of naive CD4+ and CD8+ T cells. Started Oct 2011; status: active, not recruiting.

02

Drugs

antithymocyte globulin rabbitdeuterated water
03

Conditions

kidney allograft rejectionlymphocytopenia

Beyond the preview

Go deeper on NL-OMON35541.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON35541.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call